1. Introduction {#sec1}
===============

Priapism is defined as the persistence of a complete or partial erection beyond four hours, after orgasm/cessation or without any sexual stimulation.

There are three different types of priapism: high-flow priapism, ischemic priapism, and recurrent priapism \[[@B1]\]. Ischemic priapism is the most frequent and serious type requiring emergency management to avoid complications such as erectile dysfunction. \[[@B1]\]. In the United States, ischemic priapism presents more commonly with an incidence of up to 5.34 per 100,000 men per year \[[@B2]\].

The hematological disorder is responsible to 20% of priapism \[[@B3]\]. Priapism resulting from acute or chronic myeloid leukemia is unusual \[[@B4]\]. In adult patients with leukemia, the incidence of priapism is estimated to be approximately 5% \[[@B5]\] and 15% in the pediatric population \[[@B6]\].

Emergency management requires combined systemic treatment along with local treatment of the corpora cavernosa \[[@B7]\]. We report two clinical cases of priapism occurring with of myeloid leukemia received in the urological emergency department.

2. Case 1 {#sec2}
=========

A case of a 46-year-old male patient was consulted for a painful erection for 48 hours without any previous sexual stimulation, trauma, or medication intake.

Physical assessment revealed a male with good general condition, grade 1 splenomegaly, hepatomegaly with hepatic notch at 14 cm, rigidity of the corpora cavernosa, and a flaccid glans penis.

The emergency laboratory workup showed Hemoglobin: 9.7 g/dl, Reds cells: 2920000/mm^3^, White Blood Cell: 526000/mm^3^, Platelets: 412000/mm^3^, Lactate Dehydrogenase: 1491 U/I, Urea: 0.23 g/L, and Creatinine level: 7.8 mg/L.

Blood smear ([Figure 1](#fig1){ref-type="fig"}) showed Myeloblast: 12%, Promyelocytes: 85%, Myelocytes: 11%, and Eosinophil: 4%.

The emergency management consisted of rehydration, an infusion of sodium bicarbonate, a puncture of the corpora cavernosa, injection of phenylephrine along with administration of hydroxycarbamide. Detumescence was achieved after 36 hours.

Subsequently, a myelogram showed bone marrow hyperplasia and a karyotype revealed a translocation between chromosomes 9 and 22 confirming the diagnosis of chronic myeloid leukemia. The patient was continued with doses of imatinib.

3. Case 2 {#sec3}
=========

A case of a 9-year-old child was seen in the emergency department for a sudden onset of a painful erection evolving for about 36 hours without any previous sexual stimulation, trauma, or medication intake.

The examination showed Pallor of the conjunctival mucosa, grade 1 splenomegaly, gingival enlargement, rigidity of the corpora cavernosa, and a flaccid glans penis ([Figure 2](#fig2){ref-type="fig"}).

The emergency laboratory workup: Hemoglobin: 3.4 g/dl, Reds cells: 1090000/mm^3^, White Blood Cell: 82000/mm^3^, Platelets: 81000/mm^3^, Neutrophils: 1% or 824/mm^3^, Eosinophils: 4% or 3296/mm^3^, Lymphocytes-h: 3% or 2472/mm^3^, Hematocrit: 11%, Urea: 0.21 g/L Creatinine level: 06 mg/L, and Blood smear: Blasts: 92%.

The emergency management consisted of penile skin refrigeration, rehydration, puncture of the corpora cavernosa with injection of phenylephrine, and induction of chemotherapy with vincristine and prednisolone, which achieved detumescence in 12 hours.

The bone marrow biopsy performed later confirmed an acute myeloid leukemia ([Figure 3](#fig3){ref-type="fig"}). Hemoglobin electrophoresis was performed and ruled out sickle cell disease.

4. Discussion {#sec4}
=============

Priapism is a rare urological emergency. Ischemic priapism results from an obstruction of the venous blood and is manifested by a painful erection with rigidity of the corpora cavernosa and a flaccid glans penis \[[@B7]\]. It is the most urgent and frequent type requiring emergency care to prevent complications such as erectile dysfunction.

To date, less than 20 cases of priapism and chronic myeloid leukemia \[[@B2], [@B3], [@B5], [@B8]--[@B15]\] have been reported and 2 cases of priapism and acute lymphoblastic leukemia \[[@B16], [@B17]\] ([Table 1](#tab1){ref-type="table"}).

In Senegal, sickle cell disease is responsible for the majority of priapism cases \[[@B18]\]. Leukemia is rarely complicated by priapism. When it occurs, it is most often caused by chronic myeloid leukemia and more rarely by acute lymphoid leukemia or acute myeloid leukemia \[[@B9]\].

Hyperleukocytosis is considered the underlying pathology of priapism in these instances. The main mechanism is the aggregation of leukemia cells in the corpora cavernosa and the dorsal vein of the penis. Other accessory mechanisms are venous congestion of the corpora cavernosa secondary to mechanical pressure from the abdominal veins draining the spleen or infiltration of the sacral nerves or the central nervous system by leukemia cells \[[@B9]\].

Vadakan and Ortega described a case of priapism, which occurred from an acute lymphoid leukemia without hyperleukocytosis suggesting a disturbance of the central or peripheral nervous system \[[@B19]\]. Chang et al. have described priapism secondary to acute myeloid leukemia due to the direct penetration of the penis by leukemia cells \[[@B8]\]. As in most of the reports described \[[@B9]--[@B17]\], hyperleukocytosis was the most likely cause of priapism in the two cases of this report.

The American Urology Association \[[@B7]\] recommended combining systemic treatment of the organic cause with local treatment of the corpora cavernosa in cases of priapism secondary to leukemia. Systemic treatment is indicated for cytoreduction. It combines hydroxyurea with imatinib with or without leukapheresis to reduce hyperviscosity in chronic myeloid leukemia \[[@B8], [@B9], [@B20], [@B21]\] and chemotherapy in acute myeloid leukemia \[[@B22]\].

The local treatment at the level of the cavernous bodies involves a puncture evacuating the blood of the cavernous bodies along the lateral route at the penoscrotal or trans-glandular junction with an injection of alpha sympathomimetic agent. Amongst these agents, the use of etilefrine or phenylephrine has been favored because of their pure alpha-stimulating nature and better cardiac tolerance \[[@B21]\].

Other treatments such as radiotherapy of the penis, spinal anesthesia \[[@B23]\], irradiation of the spine \[[@B23], [@B24]\], the application of hot compresses \[[@B25]\], or penile refrigeration \[[@B19], [@B23]\] have been described with less satisfactory results.

The review showed that corporal aspiration/irrigation or a distal shunt was sufficient in achieving at least partial detumescence \[[@B2], [@B5], [@B8]\]. These procedures were followed by the treatment of the underlying leukemia with adequate hydration, hydroxyurea, imatinib, and leukapheresis \[[@B10]--[@B17]\]. The reports showed disease remission at a maximum 6-month follow-up with adequate erectile function.

5. Conclusion {#sec5}
=============

Priapism is a usual presentation of myeloid leukemia and exceptionally rare association. A blood cell count showing hyperleukocytosis should suggest leukemia.

Emergent combination of systemic treatment with local treatment in the corpora cavernosa provides satisfactory results.

Special thanks are due to the Urology-andrology department, Hôpital Aristide Le Dantec (Sénégal).
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###### 

Literature review of priapism and leukemia from 2003 to 2020 using the PubMed database.

  Series                             Age      Diagnosis                      Presenting symptoms                     WBC cell/mm^3^   Platelet count cell/mm^3^   Treatment of priapism and leukemia                                                 Outcome
  ---------------------------------- -------- ------------------------------ --------------------------------------- ---------------- --------------------------- ---------------------------------------------------------------------------------- --------------------------------------
  Becerra-Pedraza et al. \[[@B2]\]   52 yrs   Chronic myeloid leukemia       Priapism for 144 hrs, fatigue, pallor   282 000                                      Corpora cavernosa drainage-irrigation penile shunts. Dasatinib                     No ED on follow-up
  Hazra et al. \[[@B3]\]             14 yrs   Chronic myeloid leukemia       Priapism for 24 hrs                     226 900          310 000                     Cavernosal aspiration and phenylephrine irrigation                                 No recurrence at 2-month follow-up
  Khan et al. \[[@B5]\]              16 yrs   Chronic myeloid leukemia       Priapism for 264 hrs                    614 800          7 090 000                   Glans-cavernosal shunt hydroxyurea and allopurinol                                 Achieved detumescence. No info on ED
  Nerli et al. \[[@B8]\]             19 yrs   Chronic myeloid leukemia       Priapism for 24 hrs                     296 800          936 000                     Corporal aspiration and phenylephrine irrigation hydroxyurea and imatinib          Achieved detumescence. No info on ED
  Minckler et al. \[[@B9]\]          18 yrs   Chronic myeloid leukemia       Recurrent priapism                      5 880 000        1 090 000                   Hydroxyurea and imatinib                                                           No info on follow-up
  Chang et al. \[[@B10]\]            21 yrs   Chronic myeloid leukemia       Priapism for 19 hrs                     216 800          1 746 000                   Cavernosa aspiration and epinephrine irrigation hydroxyurea and interferon         No ED on follow-up
  Qu et al. \[[@B11]\]               18 yrs   Chronic myeloid leukemia       Priapism for 72 hrs                     257 000          5 450 000                   Cavernosa-corpus spongiosum shunt, imatinib                                        No ED at 3-month follow-up
  Yoshida et al. \[[@B12]\]          29 yrs   Chronic myeloid leukemia       Priapism for 48 hrs                     263 000                                      Glans-cavernosal shunt hydroxyurea and imatinib                                    No ED at 5-month follow-up
  Tazi \[[@B13]\]                    33 yrs   Chronic myeloid leukemia       Priapism for 22 hrs                     400 000          1 200 000                   Cavernosa aspiration and epinephrine irrigation                                    No recurrence on follow-up
  Ponniah et al. \[[@B14]\]          19 yrs   Chronic myeloid leukemia       Priapism for 18 hrs                     513 000                                      Failed cavernosal aspiration + leukapheresis                                       No ED on follow-up
  Ergenc et al. \[[@B15]\]           18 yrs   Chronic myeloid leukemia       Priapism for 72 hrs                     100 000          1 002 000                   İmatinib, allopurinol + leukapheresis                                              No ED at 6-month follow-up
  Gupta et al. \[[@B16]\]            10 yrs   Acute lymphoblastic leukemia   Priapism, fever, headache               693 000          40 000                      Corporal aspiration followed by phenylephrine irrigation, allopurinol + steroids   Died after 48 hours
  Güzelküçük et al. \[[@B17]\]       9 yrs    Acute lymphoblastic leukemia   Priapism for 18 hrs                     583 000          51 000                      Corporal aspiration followed by hydroxyurea, allopurinol + leukapheresis           Achieved detumescence

ED: erectile dysfunction; Hrs: hours; WBC: White Blood Cell; Yrs: years.
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